JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1006 Angiotensin I (human, mouse, rat)

Summary: Precursor of angiotensin II

≥129.6 mg/mL
B5550 HBX 41108

Summary: ubiquitin-specific protease (USP) 7 inhibitor
B4815 LCZ696

Summary: A first in class ARNi (angiotensin receptor neprilysin inhibitor)

≥45.05 mg/mL
B4818 WAY-262611

Summary: β-Catenin agonist

insoluble in EtOH; insoluble in H2O; ≥8.95 mg/mL
B4910 SAR407899

Summary: ATP-competitive ROCK inhibitor

≥8.28 mg/mL
B4942 Bryostatin 2

Summary: Protein kinase C (PKC) activator

Soluble in ethanol
A8708 Sephin1
1 Citation

Target: phosphatases

Summary: Selective PPP1R15A inhibitor

insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
B5959 GSK J4 free base

Summary: histone demethylase JMJD3/UTX inhibitor
B5868 MK3102

Summary: Novel long-acting DPP-4 inhibitor

insoluble in EtOH; insoluble in H2O; ≥17.15 mg/mL
B5954 Dasatinib Monohydrate

Target: PDGFR|c-Kit|Bcr-Abl|Src

Summary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.

≥25.3 mg/mL